Da-Sol Kim

Da-Sol Kim

Auto-generated profile, based on publicly available information

Da-Sol Kim

Department of Physical Medicine and Rehabilitation, Jeonbuk National University Medical School, Jeonju, Republic of Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Brain & Neurorehabilitation
Verified
Journal Article
Open access
PDF file
BRByungju Ryu
Byungju Ryu
Byung-Mo OhByung-Mo Oh
Byung-Mo Oh
DKDae Yul Kim
Dae Yul Kim
DKDa-Sol Kim
Da-Sol Kim
deog young kimdeog young kim
deog young kim
KGKSNR Stroke CPG Writing Group
KSNR Stroke CPG Writing Group
Kim DY, et al. Brain Neurorehabil. 2023 Jul;16(2):e18. https://doi.org/10.12786/bn.2023.16.e18

16 June 2019 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
EKEu-Deum Kim
Eu-Deum Kim
YWYu Hui Won
Yu Hui Won
SPSung-Hee Park
Sung-Hee Park
JSJeon-Hwan Seo
Jeon-Hwan Seo
DKDa-Sol Kim
Da-Sol Kim
Gi-Wook KimGi-Wook Kim
Gi-Wook Kim
Objective. Studies regarding the combination of ultrasound and transcutaneous electrical nerve stimulation (TENS) are rarely reported. In this study, we aimed to elucidate the efficacy and safety of a stimulator using low-intensity pulsed ultrasound (LIPUS) combined with TENS in patients with painful knee osteoarthritis (OA). We evaluated the effectiveness of this therapy against pain, physical function, and cartilage regeneration. Moreover, we aim to prove the superiority of the effects of LIPUS combined with TENS therapy compared with only TENS therapy.Methods. Of the 40 included patients, aged 45–85 years with painful knee OA, 20 patients received only TENS therapy and 20 patients received LIPUS combined with TENS therapy for 8 weeks (a total of more than 80 treatment sessions). We evaluated visual analogue scale (VAS), Western Ontario and McMaster Universities (WOMAC) osteoarthritis index, MOS 36-Item Short-Form Health Survey (SF-36), and femoral articular cartilage (FAC) thickness. The evaluation was performed at three visits: visit 1 (V1, pretreatment, within 28 days after screening), visit 2 (V2, posttreatment period 1, ±3 days after treatment), and visit 3 (V3, posttreatment period 2, 21 ± 3 days after treatment).Results. We expected that LIPUS combined with TENS therapy would be superior to only TENS therapy. However, there was no significant difference between the two therapies. In the within-group comparison, both treatments (only TENS therapy and LIPUS with TENS therapy) demonstrated statistical differences from baseline values for pain and physical function outcomes. FAC thickness showed no significant differences after treatment in both groups.Conclusion. The effects of a stimulator using LIPUS with TENS on pain relief and functional improvement were not superior to the only TENS therapy. Cartilage regeneration, which was expected as an additional benefit of LIPUS, was also not significantly evident. Therefore, further investigation is warranted to determine whether the combination therapy is beneficial. This trial is registered withKCT0003883.

1 January 2023 in Brain & Neurorehabilitation
Verified
Journal Article
Open access
PDF file
ELEun Hee Lim
Eun Hee Lim
DKDa-Sol Kim
Da-Sol Kim
YWYu Hui Won
Yu Hui Won
SPSung-Hee Park
Sung-Hee Park
JSJeong-Hwan Seo
Jeong-Hwan Seo
Gi-Wook KimGi-Wook Kim
Gi-Wook Kim
Lim EH, et al. Brain Neurorehabil. 2023 Mar;16(1):e4. https://doi.org/10.12786/bn.2023.16.e4

1 January 2024 in Brain & Neurorehabilitation
Verified
Journal Article
Open access
PDF file
DKDa-Sol Kim
Da-Sol Kim
Gi-Wook KimGi-Wook Kim
Gi-Wook Kim
Kim DS, et al. Brain Neurorehabil. 2024 Mar;17(1):e8. https://doi.org/10.12786/bn.2024.17.e8

2 June 2025 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
DKDa-Sol Kim
Da-Sol Kim
YWYu Hui Won
Yu Hui Won
SPSung-Hee Park
Sung-Hee Park
JSJeong-Hwan Seo
Jeong-Hwan Seo
MKMyoung-Hwan Ko
Myoung-Hwan Ko
Gi-Wook KimGi-Wook Kim
Gi-Wook Kim
Background: Treatment of Achilles tendon injury varied from surgical to nonsurgical management, such as immobilization, step-by-step physical therapy, or injection with regenerative agents. Regenerative treatment has been studied using polydeoxyribonucleotide (PDRN), atelocollagen, prolotherapy, platelet-rich plasma, and mesenchymal stem cells. PDRN and atelocollagen monotherapy have been known to promote mitigation of fibroblasts, synthesis of collagen fibers, and secretion of growth factors for tissue remodeling. Purpose: To compare the therapeutic effects of PDRN, atelocollagen, and PDRN + atelocollagen treatments in rats with a partial Achilles tendon injury. Study Design: Controlled laboratory study. Methods: A total of 32 Sprague-Dawley rats, aged 8 weeks, were divided into 4 groups—normal saline, PDRN, atelocollagen, and PDRN + atelocollagen. The partial Achilles tendon injury was induced using punch biopsy tools. The treatment was administered 1 day after the injury. The biomechanical evaluation using load to failure and energy absorbed, histology related to inflammation and collagen fiber arrangement, and immunohistochemistry evaluation with collagen-I, transforming growth factor beta1, vascular endothelial growth factor (VEGF), and fibroblast growth factor were measured at 1 week and 4 weeks. Results: The tensile strength test conducted at week 4 after injury measured a significantly higher energy absorbed in the PDRN + atelocollagen group than that in the control group. The hematoxylin and eosin (H&E) stain showed that neutrophil invasion was significantly higher in the control group compared with the other groups. Collagen fiber arrangement relatively increased in the atelocollagen and PDRN + atelocollagen groups. After 4 weeks, H&E in all groups showed decreased neutrophil invasion and lower inflammation index. Immunohistochemistry exhibited increased levels of collagen I in the PDRN group compared with the control group and an increased level of VEGF in the PDRN + atelocollagen group compared with the other groups at week 1. After 4 weeks, a high expression of collagen I, transforming growth factor beta1, and fibroblast growth factor was observed in the PDRN and PDRN + atelocollagen groups; the expression of VEGF showed an upward trend in the atelocollagen group compared with the PDRN + atelocollagen group. Conclusion: The combined use of PDRN and atelocollagen resulted in increased energy absorbed by the repaired tendons and increased expression of healing growth factors in a partial tendon injury rat model. These benefits appear to be greater than the use of either agent alone. The combined use of PDRN and atelocollagen should be investigated in human patients with tendon injuries. Clinical Relevance: PDRN and atelocollagen are commonly used in patients with tendon injuries; however, the comparison of therapeutic effects or synergistic effects has not yet been studied.

30 September 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Gi-Wook KimGi-Wook Kim
Gi-Wook Kim
NSNanhee Song
Nanhee Song
MPMi-Ran Park
Mi-Ran Park
TKTae-Eon Kim
Tae-Eon Kim
DKDa-Sol Kim
Da-Sol Kim
DLDong-Won Lee
Dong-Won Lee
Ultrasound is clinically used for diagnosis and interventions for musculoskeletal injuries like muscle contusion, but contrast of ultrasonography still remains a challenge in the field of the musculoskeletal system. A level of hydrogen peroxide (H2O2) is known to be elevated during mechanical tissue damage and therefore H2O2 can be exploited as a diagnostic and therapeutic marker for mechanical injuries in the musculoskeletal system. We previously developed poly(vanillin-oxalate) (PVO) as an inflammation-responsive polymeric prodrug of vanillin, which is designed to rapidly respond to H2O2 and exert antioxidant and anti-inflammatory activities. The primary aim of this study is to verify whether PVO nanoparticles could serve as contrast agents as well as therapeutic agents for musculoskeletal injuries simultaneously. In a rat model of contusion-induced muscle injury, PVO nanoparticles generated CO2 bubbles to enhance the ultrasound contrast in the injury site. A single intramuscular injection of PVO nanoparticles also suppressed contusion-induced muscle damages by inhibiting the expression of pro-inflammatory cytokines and inflammatory cell infiltration. We, therefore, anticipate that PVO nanoparticles have great translational potential as not only ultrasound imaging agents but also therapeutic agents for the musculoskeletal disorders such as contusion.